A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13. (2018)

First Author: Reglinski M
Attributed to:  Development and testing of novel recombinant pnemococcal glyconjugate vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41541-018-0090-4

PubMed Identifier: 30393571

Publication URI: http://europepmc.org/abstract/MED/30393571

Type: Journal Article/Review

Volume: 3

Parent Publication: NPJ vaccines

ISSN: 2059-0105